- Home
- VOR vs JRS Comparison
VOR vs JRS Comparison
Compare VOR & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- JRS
- Stock Information
- Founded
- VOR 2015
- JRS 2001
- Country
- VOR United States
- JRS United States
- Employees
- VOR N/A
- JRS N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- JRS Finance/Investors Services
- Sector
- VOR Health Care
- JRS Finance
- Exchange
- VOR Nasdaq
- JRS Nasdaq
- Market Cap
- VOR 261.0M
- JRS 241.3M
- IPO Year
- VOR 2021
- JRS N/A
- Fundamental
- Price
- VOR $1.57
- JRS $8.11
- Analyst Decision
- VOR Buy
- JRS
- Analyst Count
- VOR 6
- JRS 0
- Target Price
- VOR $3.90
- JRS N/A
- AVG Volume (30 Days)
- VOR 4.4M
- JRS 86.6K
- Earning Date
- VOR 11-06-2025
- JRS 01-01-0001
- Dividend Yield
- VOR N/A
- JRS 8.87%
- EPS Growth
- VOR N/A
- JRS N/A
- EPS
- VOR N/A
- JRS N/A
- Revenue
- VOR N/A
- JRS N/A
- Revenue This Year
- VOR N/A
- JRS N/A
- Revenue Next Year
- VOR N/A
- JRS N/A
- P/E Ratio
- VOR N/A
- JRS N/A
- Revenue Growth
- VOR N/A
- JRS N/A
- 52 Week Low
- VOR $0.13
- JRS $5.95
- 52 Week High
- VOR $3.29
- JRS $8.00
- Technical
- Relative Strength Index (RSI)
- VOR 33.31
- JRS 52.02
- Support Level
- VOR $1.80
- JRS N/A
- Resistance Level
- VOR $2.03
- JRS $8.38
- Average True Range (ATR)
- VOR 0.13
- JRS 0.08
- MACD
- VOR -0.05
- JRS -0.29
- Stochastic Oscillator
- VOR 10.30
- JRS 96.78
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.